| Literature DB >> 19371446 |
Wayne Hoskins1, Henry Pollard, Chris Daff, Andrew Odell, Peter Garbutt, Andrew McHardy, Kate Hardy, George Dragasevic.
Abstract
BACKGROUND: Our understanding of the effects of football code participation on low back pain (LBP) is limited. It is unclear whether LBP is more prevalent in athletic populations or differs between levels of competition. Thus it was the aim of this study to document and compare the prevalence, intensity, quality and frequency of LBP between elite and semi-elite male Australian football code participants and a non-athletic group.Entities:
Mesh:
Year: 2009 PMID: 19371446 PMCID: PMC2674424 DOI: 10.1186/1471-2474-10-38
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Figure 1The anatomical boundaries representing the low back.
Subject characteristics and results of the QVAS and MPQ-SF questionnaires by group (n = 779)
| Number | 271 | 360 | 148 | |
| Mean age (SD) | 23.3 (4.0) | 23.6 (4.0) | 23.9 (4.5) | 0.42 |
| Age range | 17–39 | 16–46 | 18–39 | |
| LBP nowa, b (SD) | 25.4 (22.6) | 17.7 (21.5) | 11.2 (15.3) | <0.001 |
| LBP averagea (SD) | 24.9 (19.8) | 19.4 (19.0) | 11.2 (12.3) | <0.001 |
| LBP besta (SD) | 8.5 (11.9) | 5.2 (9.1) | 2.3 (4.9) | <0.001 |
| LBP worsta (SD) | 56.2 (27.6) | 48.1 (28.6) | 39.8 (25.3) | <0.001 |
| Sensory pain scoreb (SD) | 16.5 (14.0) | 12.8 (12.4) | 9.8 (9.2) | <0.001 |
| Affective pain scoreb (SD) | 8.4 (13.2) | 6.9 (11.6) | 5.6 (8.2) | 0.047 |
| Total pain scoreb (SD) | 14.3 (13.0) | 12.2 (13.6) | 9.3 (9.9) | <0.001 |
a Questions from the QVAS
"LBP now" refers to the question: How much LBP do you have right now?
"LBP average" refers to the question: What is your typical or average pain?
"LBP best" refers to the question: What is your pain level at its best (How close to "0" does your pain get at its best)?
"LBP worst" refers to the question: What is your pain level at its worst (How close to "10" does your pain get at its worst)?
b Questions from the MPQ-SF
Self reported present LBP intensity by category (none, mild, discomforting) by group (n = 779)
| Elite (n = 271) | None (n = 60, 22.1%) | 0.54 | 0.38–0.75 |
| Mild (n = 97, 35.8%) | 0.99 | 0.73–1.35 | |
| Discomforting + (n = 114, 42.1%) | 1.75 | 1.29–2.38 | |
| Semi-elite (n = 360) | None (n = 120, 33.3%) | 1.31 | 0.96–1.77 |
| Mild (n = 133, 36.9%) | 1.08 | 0.81–1.45 | |
| Discomforting + (n = 107, 29.7%) | 0.71 | 0.53–0.96 | |
| Non-athletic (n = 148) | None (n = 56, 37.8%) | 1.53 | 1.05–2.22 |
| Mild (n = 50, 33.8%) | 0.89 | 0.61–1.30 | |
| Discomforting + (n = 42, 28.4%) | 0.74 | 0.50–1.09 |
a Question from MPQ-SF
Breakdown of discomforting, distressing and excruciating pain for the groups were elite (n = 88, 24, 2), semi-elite (n = 93, 8, 6) and non-athletic (n = 39, 2, 1) respectively. These levels of pain have been combined and are described as "discomforting +"
LBP profile (pain association, onset and frequency) by group (n = 779)
| Elite (n = 271) | N/A (n = 13) | 0.39 | 0.21–0.73 |
| Yes (n = 229) | 3.40 | 2.34–4.94 | |
| No (n = 29) | 0.32 | 0.21–0.50 | |
| Semi-elite (n = 360) | N/A (n = 42) | 1.78 | 1.08–2.92 |
| Yes (n = 235) | 0.69 | 0.50–0.93 | |
| No (n = 83) | 1.21 | 0.86–1.71 | |
| Non-athletic (n = 148) | N/A (n = 16) | 1.27 | 0.71–2.29 |
| Yes (n = 78) | 0.40 | 0.28–0.58 | |
| No (n = 54) | 2.66 | 1.80–3.94 | |
| Elite (n = 271) | N/A (n = 85) | 0.58 | 0.43–0.80 |
| 0–3 months (n = 110) | 1.43 | 1.06–1.95 | |
| >3 months (n = 76) | 1.25 | 0.89–1.74 | |
| Semi-elite (n = 360) | N/A (n = 156) | 1.34 | 1.01–1.79 |
| 0–3 months (n = 117) | 0.80 | 0.60–1.08 | |
| >3 months (n = 87) | 0.90 | 0.65–1.24 | |
| Non-athletic (n = 148) | N/A (n = 67) | 1.34 | 0.93–1.92 |
| 0–3 months (n = 47) | 0.83 | 0.57–1.21 | |
| >3 months (n = 34) | 0.86 | 0.56–1.31 | |
| Elite (n = 271) | N/A (n = 85) | 0.61 | 0.45–0.83 |
| Yes (n = 173) | 2.79 | 2.05–3.78 | |
| No (n = 13) | 0.22 | 0.12–0.41 | |
| Semi-elite (n = 360) | N/A (n = 151) | 1.27 | 0.95–1.69 |
| Yes (n = 157) | 0.75 | 0.56–0.99 | |
| No (n = 52) | 1.14 | 0.76–1.72 | |
| Non-athletic (n = 148) | N/A (n = 67) | 1.38 | 0.96–1.99 |
| Yes (n = 40) | 0.34 | 0.23–0.50 | |
| No (n = 41) | 3.34 | 2.14–5.19 | |
| Elite (n = 271) | N/A (n = 51) | 0.84 | 0.58–1.22 |
| Daily or weekly (n = 107) | 1.77 | 1.29–2.42 | |
| Fortnightly + (n = 113) | 0.68 | 0.50–0.91 | |
| Semi-elite (n = 360) | N/A (n = 84) | 1.35 | 0.95–1.91 |
| Daily or weekly (n = 111) | 0.96 | 0.71–1.30 | |
| Fortnightly + (n = 165) | 0.85 | 0.64–1.13 | |
| Non-athletic (n = 148) | N/A (n = 26) | 0.78 | 0.49–1.25 |
| Daily or weekly (n = 26) | 0.40 | 0.26–0.64 | |
| Fortnightly + (n = 96) | 2.34 | 1.62–3.40 | |
a Question: if applicable, was your first ever attack or episode of LBP a result of your sporting commitments and activities or not related to this?
N/A = I have not had a first ever attack or episode of LBP
b Question: when did your current episode of LBP commence?
N/A = I do not have a current episode of LBP
c Question: if applicable, is your current episode of LBP a result of your sporting commitments and activities or not related to this?
N/A = I do not have a current episode of LBP
d Question: how often do you experience LBP?
N/A = I do not experience LBP
"Fortnightly +" relates to experiencing LBP on a fortnightly basis or less frequently